Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
07/14/2011 | US20110172150 Tissue regeneration method |
07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
07/14/2011 | US20110171303 Dosage form containing (s)-pantoprazole as active ingredient |
07/14/2011 | US20110171300 Delta 9 tetrahydrocannabinol derivatives |
07/14/2011 | US20110171295 Immediate release compositions of acid labile drugs |
07/14/2011 | US20110171294 Enzyme composition and application thereof in the treatment of pancreatic insufficiency |
07/14/2011 | US20110171276 Non-Viral Compositions and Methods for Transfecting Gut Cells In Vivo |
07/14/2011 | US20110171275 Gastroretentive drug delivery system, preparation method and use thereof |
07/14/2011 | US20110171273 Stable anti-nausea oral spray formulations and methods |
07/14/2011 | US20110171270 Novel solid state forms of laquinimod and its sodium salt |
07/14/2011 | US20110171269 Method for manufacturing uniform size polymeric nanoparticles containing poorly soluble drugs |
07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
07/14/2011 | US20110171220 Pd-1 specific antibodies and uses thereof |
07/14/2011 | US20110171215 Pd-1 specific antibodies and uses thereof |
07/14/2011 | US20110171191 Suppression of neuroendocrine diseases |
07/14/2011 | US20110171178 Compositions and methods of using proislet peptides and analogs thereof |
07/14/2011 | US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds |
07/14/2011 | US20110171144 Functional Micelles for Hard Tissue Targeted Delivery of Chemicals |
07/14/2011 | US20110171143 Method of maintaining oral health in animals |
07/14/2011 | US20110171140 Absorption of therapeutic agents across mucosal membranes or the skin |
07/14/2011 | CA2786056A1 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene |
07/14/2011 | CA2786019A1 Plasma kallikrein binding proteins |
07/14/2011 | CA2784647A1 Inhibitors of sphingosine kinase |
07/14/2011 | CA2781260A1 Oral care compositions for use with an oral light device |
07/14/2011 | CA2780821A1 Mmp-13 inhibitors for the treatment of periodontitsis |
07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
07/13/2011 | EP2343314A2 Calcium fluoride phosphopeptide complexes |
07/13/2011 | EP2343292A1 Novel prostaglandin i<sb>2</sb>derivative |
07/13/2011 | EP2343289A1 Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent |
07/13/2011 | EP2343081A1 Interferon analogs |
07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
07/13/2011 | EP2343072A1 Remedy |
07/13/2011 | EP2343067A1 Pharmaceutical composition for the eradication of helicobacter pylori and preparation method thereof |
07/13/2011 | EP2343066A1 Therapeutic agent for hepatitis c |
07/13/2011 | EP2343065A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
07/13/2011 | EP2343063A1 Pharmaceutical preparations comprising a COS releasing compound |
07/13/2011 | EP2342335A1 Novel gene cluster |
07/13/2011 | EP2342200A2 Compounds which selectively modulate the cb2 receptor |
07/13/2011 | EP2342199A2 Compounds which selectively modulate the cb2 receptor |
07/13/2011 | EP2342178A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
07/13/2011 | EP2341985A1 Dental formulations for the prevention of dental erosion |
07/13/2011 | EP2098598B1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
07/13/2011 | EP1863526B1 Live attenuated rotavirus vaccine for oral administration |
07/13/2011 | EP1789068B1 Composition and use for prevention or treatment of stomatitis |
07/13/2011 | EP1543039B1 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
07/13/2011 | EP1486491B1 Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
07/13/2011 | EP1178796B1 Orazamide orotate for the prevention of liver damage |
07/13/2011 | CN1957938B Effervescence tablet of Glucurolactone, and preparation method |
07/13/2011 | CN1353609B Amide substituted imidazoquinolines |
07/13/2011 | CN102123735A Agent for induction/maintenance of remission |
07/13/2011 | CN102123718A Treatment of gut motility disorders |
07/13/2011 | CN102123716A Compositions and methods for treating viral infections |
07/13/2011 | CN102120952A Health wine with functions of nourishing yin and tonifying yang |
07/13/2011 | CN102120773A Dual specificity antibodies and methods of making and using |
07/13/2011 | CN102120724A 5-amino-4-hydroxy-7-benzyl-8-methylnonanamide derivative, preparation method thereof and application thereof in medicines |
07/13/2011 | CN102120030A Medicament of ilaprazole chemical structure and application thereof |
07/13/2011 | CN102120011A Medicament for treating toothache |
07/13/2011 | CN102120008A Traditional Chinese medicine for treating icteric hepatitis |
07/13/2011 | CN102120007A Medicament for preventing and treating complications caused by <131>I therapy of differentiated thyroid carcinoma (DTC) |
07/13/2011 | CN102120005A Traditional Chinese medicine for soothing liver, regulating qi and promoting bile flow and preparation method and quality standard thereof |
07/13/2011 | CN102119999A Preparation method of oral solution capable of tonifying qi and nourishing blood |
07/13/2011 | CN102119997A Method for establishing HPLC (high performance liquid chromatography) finger-print of ophiopogon japonicus and standard finger-print thereof |
07/13/2011 | CN102119995A Traditional Chinese medicament for treating gum swelling pain |
07/13/2011 | CN102119992A Pharmaceutical preparation prepared from fresh motherwort and fresh aloe and preparation method thereof |
07/13/2011 | CN102119979A 口腔溃疡复方制剂 Mouth ulcers compound preparation |
07/13/2011 | CN102119973A Quality control method for gardenia percolate |
07/13/2011 | CN102119966A Preparation method of Chinese medicinal preparation for treating hepatitis disease by microwave-assisted extraction |
07/13/2011 | CN102119952A Ultrasonic extraction preparation method of Chinese traditional medicine preparation for treating lumbago due to kidney deficiency |
07/13/2011 | CN102119945A Method for preparing ultrasonic extracted Chinese medicinal preparation for treating qi deficiency |
07/13/2011 | CN102119944A Dammarane type glycoside composition particles |
07/13/2011 | CN102119939A Angiosperm bee pollen water extract for treating fatty liver and preparation method and application thereof |
07/13/2011 | CN102119938A Folk Chinese herb medicine fruiting eight trigram-shaped maple root wine |
07/13/2011 | CN102119933A Application of taurochenodeoxycholic acid in prevention and treatment of liver injury |
07/13/2011 | CN102119927A Enteric-coated pellet preparation of proton pump inhibitor and preparation method thereof |
07/13/2011 | CN102119821A Health-protecting material, application thereof in preparing health-protecting pillow and cushion, and health-protecting pillow and cushion |
07/13/2011 | CN102119776A Dried orange peel extract and preparation method and use thereof |
07/13/2011 | CN101690739B Preparation method of dogbane leaf extractive |
07/13/2011 | CN101584702B Method of preparing extract of Mallotus apelta and uses for fighting hepatitis B virus |
07/13/2011 | CN101531637B A novel compound capable of restraining and blocking M2 ion channel activity and application thereof |
07/13/2011 | CN101496813B Applicance of combination in drug coating of preparing anti-hyperblastosis (vascular restenosis) support |
07/13/2011 | CN101342229B Composition of Canton love-pea vine extract, preparation method and pharmaceutical use |
07/12/2011 | US7977469 biosynthesis of long chain polyunsaturated fatty acids like DHA (docosahexaenoic acid, 22:6, n-3); stress, diabetes, cancer, inflammatory disorders, and cardiovascular disorders |
07/12/2011 | US7977455 Analogues of GLP-1 |
07/12/2011 | US7977329 Obesity therapy; using 3-benzoazepine compound |
07/12/2011 | US7977326 Supportive treatment of liver disease |
07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
07/12/2011 | US7977059 17867, a novel human aminopeptidase |
07/12/2011 | US7976870 using a sustained release oral dosage form of a therapeutically effective amount of the drug such as minocycline hydrochloride incorporated in a matrix of biocompatible, hydrophilic polymer of specified swelling properties and erosion rate |
07/12/2011 | CA2500649C Substituted arylhexadienoic acids and esters thereof, their use in the treatment of dyslipidaemia, diabetes and atherosclerosis, and processes for their preparation |
07/12/2011 | CA2499492C Methods of preparing cannabinoids from plant material |
07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
07/12/2011 | CA2475704C Colonic release formulations of prednisolone sodium metasulphobenzoate coated with amylose, ethyl cellulose and dibutyl sebacate |
07/12/2011 | CA2457528C Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) |
07/12/2011 | CA2454389C Solid composition containing bacillus-type non-pathogenic bacterial spores |
07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
07/12/2011 | CA2446776C Self-containing lactococcus strain |
07/12/2011 | CA2435611C Alpha-amino-n-hydroxy-acetamide derivatives |
07/12/2011 | CA2422617C Tripeptidyl peptidase inhibitors |
07/12/2011 | CA2405438C Hepatitis b core antigen fusion proteins |